Teva-Sunitinib 12.5 mg

Teva-Sunitinib 12.5 mg capsules are a medication used to manage certain types of cancer. This oral treatment is designed to target specific proteins involved in cancer cell growth. Teva-Sunitinib is a product of Teva Canada Limited.

Teva-Sunitinib 12.5 mg capsules are primarily used in the treatment of specific types of cancer. The active ingredient, sunitinib malate, works by inhibiting proteins that promote cancer cell proliferation. This medication is often prescribed for conditions where these proteins play a significant role in disease progression. Patients should consult their healthcare provider to determine if Teva-Sunitinib is suitable for their condition.

Common effects of Teva-Sunitinib 12.5 mg capsules may include fatigue, nausea, and diarrhea. Some users might experience changes in blood pressure or skin discoloration. These effects can vary widely among individuals, and not everyone will experience them. It is important to monitor any unusual symptoms and discuss them with a healthcare professional.

Teva-Sunitinib 12.5 mg capsules should be handled with care, following the guidance of a healthcare provider. This medication may affect liver function, so regular monitoring is advisable. Patients with a history of heart problems should use this medication cautiously. Always store Teva-Sunitinib in a cool, dry place away from children and pets.

Teva-Sunitinib 12.5 mg capsules may interact with certain medications, including those that affect liver enzymes. Alcohol consumption should be avoided as it can exacerbate side effects. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.